首页|金复康口服液精简方对顺铂所致肾小管上皮细胞凋亡的作用

金复康口服液精简方对顺铂所致肾小管上皮细胞凋亡的作用

扫码查看
为研究金复康口服液精简方(ALG-12)对顺铂(cisplatin,DDP)所致肾小管损伤的作用,将 48 只C57 小鼠随机分为对照组(control)、模型组(model)、DDP组及DDP联用ALG-12 低、中、高剂量组,在构建小鼠皮下Lewis肺癌异位移植瘤模型后连续给药 16 d,对小鼠肾组织病理变化、血清肌酐(serum creatinine,Scr)、血尿素氮(blood urea nitrogen,BUN)、肾损伤分子 1(kidney injury molecule 1,Kim-1)、中性粒细胞明胶酶相关脂质运载蛋白(neutrophil gelatinase-associated lipocalin,NGAL)、肾组织丙二醛(malondialdehyde,MDA)、总超氧歧化酶(total superoxide dismutase,T-SOD)及肾小管细胞凋亡程度进行分析,考察ALG-12 对DDP治疗非小细胞肺癌(non-small cell lung cancer,NSCLC)所致肾损伤的影响。体外构建人肾皮质近曲小管上皮细胞(HK-2)模型,通过cell counting kit(CCK)-8、细胞周期及凋亡实验评价ALG-12 含药血清对DDP 的HK-2 的细胞毒性影响。实时荧光定量PCR(real-time quantitative reverse transcription PCR,RT-qPCR)、蛋白免疫印迹(Western blot)及免疫组化用于分析ALG-12 对肿瘤蛋白p53(tumor protein p53,p53)介导的凋亡相关基因的表达水平。结果显示,ALG-12 可显著缓解Scr、BUN、Kim-1、NGAL、MDA、T-SOD的异常,减轻肾小管损伤、肾间质纤维化及肾小管细胞凋亡程度,提示ALG-12 在体内可以减轻DDP所致的肾损伤。体外细胞实验发现ALG-12 含药血清可以抑制DDP造成的HK-2细胞凋亡及周期抑制。另外ALG-12可抑制p53 信号通路上共济失调毛细血管扩张突变基因Rad3 相关激酶(ataxia-telangiectasia mutated-and Rad3-related gene,ATR)、肿瘤蛋白p53 基因(tumor protein p53 gene,Tp53)、Bcl-2绑定组件 3(Bcl-2 binding component 3,BBC3)、Bcl-2 相关X蛋白(Bcl-2 associated X protein,Bax)的转录,降低p53、Bax、剪切的半胱天冬蛋白酶3(cleaved caspase-3)的蛋白表达水平,增加B细胞淋巴瘤/白血病-2(B-cell lymphoma/leukemia 2,Bcl-2)及半胱天冬蛋白酶 3(caspase-3)的蛋白表达。研究结果表明,ALG-12 对DDP所致肾小管上皮细胞损伤具有保护作用,其机制可能与抑制p53 介导的细胞凋亡相关,为进一步开发ALG-12 提供依据。
Effect of simplified formula of Jinfukang Oral Liquid on apoptosis of renal tubular epithelial cells induced by cisplatin
In order to study the effect of the simplified formula of Jinfukang Oral Liquid(ALG-12)on renal tubular injury induced by cisplatin(DDP),48 C57 mice were divided into control group,model group,DDP group,and DDP combined with low,medium,and high dose groups of ALG-12.The mice were administered for 16 days after the establishment of the subcutaneous Lewis lung cancer heterotopic transplant tumor model of mice.The pathological changes,serum creatinine(Scr),blood urea nitrogen(BUN),kidney injury molecule 1(Kim-1),neutrophil gelatinase-associated lipocalin(NGAL),malondialdehyde(MDA),and total superoxide dismutase(T-SOD)in renal tissue and the degree of renal tubular cell apoptosis were analyzed to investigate the effect of ALG-12 on renal injury induced by DDP treatment on non-small cell lung cancer(NSCLC).The human renal cortex proximal tubule epithelial cell(HK-2)model was constructed in vitro,and the effect of ALG-12 drug-containing serum on HK-2 cytotoxicity of DDP was evaluated by CCK-8,cell cycle,and apoptosis tests.Real-time quantitative reverse transcription PCR(RT-qPCR),Western blot,and immunohistochemistry were used to analyze the expression levels of tumor protein p53-mediated apoptosis-related genes by ALG-12.The results showed that ALG-12 could significantly reduce the abnormalities of biochemical indexes like Scr,BUN,Kim-1,NGAL,MDA,and T-SOD and decrease the degree of renal tubular injury,renal interstitial fibrosis,and renal cell apoptosis,suggesting that ALG-12 could reduce the renal injury induced by DDP in vivo.In vitro cell assay found that ALG-12 containing serum could inhibit apoptosis and cell cycle arrest induced by DDP in HK-2 cells.In addition,ALG-12 inhibited the transcription of ataxia-telangiectasia mutated-and Rad3-related gene(ATR),tumor protein p53 gene(Tp53),Bcl-2 binding component 3 gene(BBC3),and Bcl-2 associated X protein gene(Bax)in the p53 signaling pathway,decreased the protein expression levels of p53,Bax,and cleaved caspase-3,and increased the protein expression levels of B-cell lymphoma/leukemia 2(Bcl-2)and caspase-3.The results suggested that ALG-12 had a protective effect on DDP-induced renal tubular epithelial cell injury,and the mechanism may be related to the inhibition of p53-mediated apoptosis,which provided a basis for further development of ALG-12.

simplified formula of Jinfukang Oral Liquidcisplatinrenal tubular injurynon-small cell lung cancerapoptosis

汪文芳、叶亮、潘铱昕、李羽禅、李仕鑫、杨冰、封亮、贾晓斌

展开 >

中国药科大学 中药学院,江苏 南京 211198

金复康口服液精简方 顺铂 肾小管损伤 非小细胞肺癌 凋亡

中国药科大学双一流新药品种项目中国药科大学双一流创新团队项目江苏省六大人才高峰创新团队项目

CPU2022PZQ14CPU2018GY11SWYY-CXTD-004

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(19)